Guangxi University Affiliated Hospital

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Liver and biliary tract cancer

Running trials

• Recruiting

  A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

  NCT06431490· Phase 1/2· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

  Contact: Yumei Zhang, Master

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer1 recruiting